| HALLMARK TNFA SIGNALING VIA NFKB |
0.00 |
0.00 |
0.00 |
| HALLMARK HYPOXIA |
0.00 |
0.00 |
0.00 |
| HALLMARK INFLAMMATORY RESPONSE |
0.00 |
0.00 |
0.00 |
| HALLMARK EPITHELIAL MESENCHYMAL TRANSITION |
0.00 |
0.00 |
0.00 |
| HALLMARK KRAS SIGNALING UP |
0.00 |
0.00 |
0.00 |
| HALLMARK IL2 STAT5 SIGNALING |
0.00 |
0.00 |
0.00 |
| HALLMARK COMPLEMENT |
0.00 |
0.00 |
0.01 |
| HALLMARK IL6 JAK STAT3 SIGNALING |
0.01 |
0.00 |
0.02 |
| HALLMARK UV RESPONSE DN |
0.00 |
0.01 |
0.03 |
| HALLMARK ALLOGRAFT REJECTION |
0.00 |
0.01 |
0.05 |
| HALLMARK COAGULATION |
0.00 |
0.01 |
0.06 |
| HALLMARK APOPTOSIS |
0.00 |
0.03 |
0.15 |
| HALLMARK ANDROGEN RESPONSE |
0.01 |
0.05 |
0.30 |
| HALLMARK MYC TARGETS V2 |
0.04 |
0.05 |
0.33 |
| HALLMARK GLYCOLYSIS |
0.02 |
0.07 |
0.41 |
| HALLMARK UV RESPONSE UP |
0.06 |
0.13 |
0.65 |
| HALLMARK ADIPOGENESIS |
0.03 |
0.12 |
0.66 |
| HALLMARK MTORC1 SIGNALING |
0.02 |
0.12 |
0.68 |
| HALLMARK P53 PATHWAY |
0.04 |
0.12 |
0.69 |
| HALLMARK KRAS SIGNALING DN |
0.11 |
0.14 |
0.76 |
